Equities research analysts expect Addus Homecare Co. (NASDAQ:ADUS) to report $0.68 earnings per share for the current quarter, according to Zacks. Five analysts have made estimates for Addus Homecare’s earnings, with the highest EPS estimate coming in at $0.70 and the lowest estimate coming in at $0.65. Addus Homecare reported earnings per share of $0.55 during the same quarter last year, which suggests a positive year over year growth rate of 23.6%. The business is scheduled to issue its next quarterly earnings results on Monday, March 2nd.
According to Zacks, analysts expect that Addus Homecare will report full year earnings of $2.33 per share for the current financial year, with EPS estimates ranging from $2.23 to $2.45. For the next year, analysts expect that the company will post earnings of $2.96 per share, with EPS estimates ranging from $2.85 to $3.18. Zacks’ earnings per share averages are an average based on a survey of research analysts that that provide coverage for Addus Homecare.
Addus Homecare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, November 4th. The company reported $0.62 EPS for the quarter, beating analysts’ consensus estimates of $0.49 by $0.13. The company had revenue of $169.80 million for the quarter, compared to analyst estimates of $160.25 million. Addus Homecare had a net margin of 3.35% and a return on equity of 8.00%. Addus Homecare’s quarterly revenue was up 23.3% on a year-over-year basis.
Several brokerages have issued reports on ADUS. Sidoti set a $115.00 price target on shares of Addus Homecare and gave the company a “buy” rating in a report on Wednesday, August 21st. Royal Bank of Canada upped their price target on shares of Addus Homecare from $90.00 to $100.00 and gave the company an “outperform” rating in a report on Wednesday. BidaskClub downgraded shares of Addus Homecare from a “strong-buy” rating to a “buy” rating in a report on Tuesday, October 29th. Stephens began coverage on shares of Addus Homecare in a report on Monday, October 21st. They issued an “overweight” rating and a $97.00 price target on the stock. Finally, William Blair reaffirmed an “outperform” rating on shares of Addus Homecare in a report on Friday, August 9th. Two investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $94.00.
NASDAQ ADUS traded down $1.23 during trading on Friday, reaching $86.57. The company’s stock had a trading volume of 150,400 shares, compared to its average volume of 131,681. The firm has a market cap of $1.32 billion, a price-to-earnings ratio of 51.22, a P/E/G ratio of 2.76 and a beta of -0.16. Addus Homecare has a twelve month low of $57.94 and a twelve month high of $92.91. The business’s fifty day moving average price is $82.95 and its 200-day moving average price is $77.90. The company has a debt-to-equity ratio of 0.15, a quick ratio of 2.84 and a current ratio of 5.07.
In other Addus Homecare news, EVP Laurie Manning sold 990 shares of the company’s stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $83.21, for a total value of $82,377.90. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 20.10% of the stock is owned by corporate insiders.
Several institutional investors and hedge funds have recently made changes to their positions in ADUS. Marshall Wace North America L.P. purchased a new position in shares of Addus Homecare during the first quarter valued at approximately $34,000. First Trust Advisors LP lifted its stake in shares of Addus Homecare by 1.1% during the first quarter. First Trust Advisors LP now owns 18,513 shares of the company’s stock valued at $1,177,000 after buying an additional 197 shares during the period. Cortina Asset Management LLC lifted its stake in shares of Addus Homecare by 5.5% during the second quarter. Cortina Asset Management LLC now owns 171,740 shares of the company’s stock valued at $12,872,000 after buying an additional 8,947 shares during the period. WINTON GROUP Ltd lifted its stake in shares of Addus Homecare by 106.7% during the second quarter. WINTON GROUP Ltd now owns 7,311 shares of the company’s stock valued at $548,000 after buying an additional 3,774 shares during the period. Finally, Exane Derivatives purchased a new position in shares of Addus Homecare during the second quarter valued at approximately $95,000. 85.54% of the stock is currently owned by institutional investors and hedge funds.
About Addus Homecare
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.
See Also: How to interpret a stock’s beta number
Get a free copy of the Zacks research report on Addus Homecare (ADUS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.